A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy

Human Reproduction

Volumn 13, Issue 8, 1998, Pages 2261-2265

  Okon, M A ^a   Lee, Sue ^a   Laird, S M ^b   Li, T C ^a  

^a Trent Regional Neonatal Unit   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

CA125; Continuous combined oestrogen progestogen therapy; Placental protein 14; Postmenopausal; Tibolone

Indexed keywords

CA 125 ANTIGEN; ESTRADIOL VALERATE PLUS NORETHISTERONE; ESTRADIOL VALERATE PLUS NORETHISTERONE ENANTATE; PLACENTA PROTEIN 14; TIBOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; MORPHOLOGY; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; UTERUS BLEEDING;

EID: 0031717541     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.8.2261     Document Type: Article

References (25)

1. Bayard, F., Damilano, S., Robel, P. and Baulieu, E.-E. (1978) Cytoplasmic and nuclear estradiol and progesterone receptors in endometrium. J. Clin. Endocrinol. Metab., 46, 635-648.
2. Beier-Hellwig, K., Sterzik, K., Bonn, B. and Beier, H.M. (1989) Contribution to the physiology and pathology of endometrial receptivity: the determination of protein pattern in human uterine secretions. Hum. Reprod., 4, 115-120.
3. Bell, S.C., Patel, S., Hales, M.W. et al. (1985) Immunochemical detection and characterization of the pregnancy associated endometrial and alpha-2 globulin secreted by the human endometrium. J. Reprod. Fertil., 74, 261-270.
4. Bolton, A.E., Pockley, A.G., Clough, K.J. et al. (1987) Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet, i, 593-595.
5. Casanas-Roux, F., Nisolle, M., Marbaix, E. et al. (1996) Morphometric, immunohistological and three-dimensional evaluation of the endometrium of menopausal women treated by oestrogen and Crinone, a new slow-release vaginal progesterone. Hum. Reprod., 11, 357-363.
6. Castelo-Branco, C., Puerto, B., Duran, M. et al. (1994) Transvaginal sonography of endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy. Maturitas, 19, 59-65.
7. Dalton, C.F., Laird, S.M., Serle, E. et al. (1995) The measurement of CA125 and placental protein 14 in uterine flushings in women with recurrent miscarriage: relation to endometrial morphology. Hum. Reprod., 10, 2680-2684.
8. Gambrell, R.D. (1982) The menopause: benefits and risks of estrogen-progestogen replacement therapy. Fertil. Steril., 37, 457-474.
9. Jacobs, I.J. and Bast, R.C. (1989) The CA125 tumour-associated antigen: a review of the literature. Hum. Reprod., 4, 1-12.
10. Joshi, S.G., Rao, R., Henriques, E.E. et al. (1986). Luteal phase concentrations of progestogen associated endometrial protein in the serum of cycling women with adequate or inadequate endometrium. J. Clin. Endocrinol. Metab., 63, 1247-1249.
11. Julkunen, M., Apter, D., Seppala, M. et al. (1986) Serum levels of placental protein-14 in non-conceptional menstrual cycles. Fertil. Steril., 45, 47-50.
12. Klentzeris, L.D., Bulmer, J.N., Li, T.C. et al. (1991) Lectin binding of endometrium in women with unexplained infertility. Fertil. Steril., 56, 600-607.
13. Li, T.C., Rogers, A.W., Dockery, P. et al. (1988) A new method of histological dating of endometrium in the luteal phase. Fertil. Steril., 50, 52-60.
14. Li, T.C., Nuttall, Klentzeris, L. and Cooke, I.D. (1992). How well does ultrasonographic measurement of endometrial thickness predict the results of histological dating? Hum. Reprod., 7, 1-5.
15. Li, T.C., Ling, E., Dalton, C. et al. (1993a) Concentration of endometrial placental protein PP14 in uterine washings throughout the menstrual cycle in normal fertile women. Br. J. Obstet. Gynaecol., 100, 460-464.
16. Li, T.C., Mackenna, A.J. and Roberts, R. (1993b) The techniques and complications of outpatient uterine washings in the assessment of endometrial function. Hum. Reprod., 8, 343-346.
17. MacLennan, A.H. (1991) Hormone replacement therapy and the menopause. Med. J. Aust., 155, 43-44.
18. McBean, J.H. and Brumsted, J.R. (1993) In vitro CA125 secretion by endometrium from women with advanced endometriosis. Fertil. Steril., 59, 89-92.
19. National Opinion Poll Survey (1991) The menopause revolution. How far have we come? Ciba Pharmaceuticals, Horsham, UK.
20. Noyes, R.W., Hertig, A.T. and Rock, J. (1950) Dating the endometrial biopsy. Fertil. Steril., 1, 3-25.
21. Okon, M.A., Lee, S. and Li, T.C. (1996) A study to examine women's knowledge, perception and acceptability of HRT. Eur. J. Menopause, 3, 47-53.
22. Osmers, R., Volksen, M. and Schauer, A. (1990) Vaginosonography for early detection of endometrial carcinoma. Lancet, 33, 1569-1571.
23. Panay, N. and Studd, J. (1997) Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum. Reprod. Update, 3, 159-171.
24. Wolman, I., Sagi, J., Ginat, S. et al. (1996) The sensitivity and specificity of vaginal sonography in detecting endometrial abnormalities in women with postmenopausal bleeding. J. Clin. Ultrasound, 24, 79-82.
25. Zeimet, A.G., Muller-Holzner, E., Marth, C. et al. (1993) Tumor marker CA125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle. Fertil. Steril, 59, 1028-1035.